Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of kynurenine aminotransferase II attenuates hippocampus‐dependent memory deficit in adult rats treated prenatally with kynurenine
Ana Pocivavsek, Gregory I. Elmer, Robert Schwarcz
Hippocampus (2018) Vol. 29, Iss. 2, pp. 73-77
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Tryptophan Metabolism as a Pharmacological Target
Morgane Modoux, Nathalie Rolhion, Sridhar Mani, et al.
Trends in Pharmacological Sciences (2020) Vol. 42, Iss. 1, pp. 60-73
Open Access | Times Cited: 223
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
Yi-Shu Huang, Joy Ogbechi, Felix I. L. Clanchy, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 149
Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents—in celebration of 80th birthday of Professor Peter Riederer
Masaru Tanaka, Eleonóra Spekker, Ágnes Szabó, et al.
Journal of Neural Transmission (2022) Vol. 129, Iss. 5-6, pp. 627-642
Closed Access | Times Cited: 77
Kynurenine emerges from the shadows – Current knowledge on its fate and function
Marta Marszałek‐Grabska, Katarzyna Walczak, Kinga Gaweł, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107845-107845
Open Access | Times Cited: 98
Activated Tryptophan-Kynurenine metabolic system in the human brain is associated with learned fear
Maria Rita Battaglia, Chiara Di Fazio, Simone Battaglia
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 42
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities
Ana Pocivavsek, Robert Schwarcz, Sophie Erhardt
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 978-1008
Closed Access | Times Cited: 9
Kynurenine Pathway in Chronic Kidney Disease: What’s Old, What’s New, and What’s Next?
Adrian Mor, Bartłomiej Kałaska, Dariusz Pawlak
International Journal of Tryptophan Research (2020) Vol. 13
Open Access | Times Cited: 51
IDO activation, inflammation and musculoskeletal disease
Joy Ogbechi, Felix I. L. Clanchy, Yi-Shu Huang, et al.
Experimental Gerontology (2019) Vol. 131, pp. 110820-110820
Open Access | Times Cited: 46
An integrated cytokine and kynurenine network as the basis of neuroimmune communication
Trevor W. Stone, Felix I. L. Clanchy, Yishu Huang, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 27
Kynurenine aminotransferase II inhibition promotes sleep and rescues impairments induced by neurodevelopmental insult
Snezana Milosavljevic, Andrew Smith, Courtney J. Wright, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Novel Activity of Oral Hypoglycemic Agents Linked with Decreased Formation of Tryptophan Metabolite, Kynurenic Acid
Kinga Bednarz, Kamila Kozieł, Ewa M. Urbańska
Life (2024) Vol. 14, Iss. 1, pp. 127-127
Open Access | Times Cited: 5
Identification of potent inhibitors of kynurenine-3-monooxygenase from natural products: In silico and in vitro approaches
Redouane Rebai, Miguel Carmena‐Bargueño, Mohammed Esseddik Toumi, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30287-e30287
Open Access | Times Cited: 5
Prenatal Stress Impacts Foetal Neurodevelopment: Temporal Windows of Gestational Vulnerability
James M. Collins, James Keane, Clara Deady, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 164, pp. 105793-105793
Closed Access | Times Cited: 5
Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
Mary E.W. Collier, Shaowei Zhang, Nigel S. Scrutton, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 6, pp. 1473-1481
Open Access | Times Cited: 29
Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases
Hualiang Shen, Xinde Xu, Yalong Bai, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115258-115258
Closed Access | Times Cited: 12
Tryptophan metabolism as a ‘reflex’ feature of neuroimmune communication: Sensor and effector functions for the indoleamine‐2, 3‐dioxygenase kynurenine pathway
Trevor W. Stone, Richard Williams
Journal of Neurochemistry (2023)
Open Access | Times Cited: 12
The Complex World of Kynurenic Acid: Reflections on Biological Issues and Therapeutic Strategy
Trevor W. Stone, L. Gail Darlington, Abdulla A.‐B. Badawy, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9040-9040
Open Access | Times Cited: 4
Potential role for kynurenine pathway in increased COVID-19 mortality of patients with schizophrenia
Pengli Wang, Zhen-Ying Li, Jie Wang, et al.
Journal of Psychiatric Research (2025) Vol. 183, pp. 289-295
Closed Access
Cognitive Sequelae of COVID‐19: Mechanistic Insights and Therapeutic Approaches
Yuhao Chen, Jing‐Shiun Jan, Chih‐Hao Yang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 3
Open Access
Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders
Michael Y. Bai, David B. Lovejoy, Gilles J. Guillemin, et al.
Complex Psychiatry (2021) Vol. 7, Iss. 1-2, pp. 19-33
Open Access | Times Cited: 25
Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
Ferenc Zádor, Gábor Nagy-Grócz, Gabriella Kékesi, et al.
Molecules (2019) Vol. 24, Iss. 20, pp. 3709-3709
Open Access | Times Cited: 26
Prenatal THC exposure raises kynurenic acid levels in the prefrontal cortex of adult rats
Sarah Beggiato, Alessandro Ieraci, Maria Cristina Tomasini, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 100, pp. 109883-109883
Open Access | Times Cited: 24
Stress-induced impairment in fear discrimination is causally related to increased kynurenic acid formation in the prefrontal cortex
Alex Klausing, Tsutomu Fukuwatari, David J. Bucci, et al.
Psychopharmacology (2020) Vol. 237, Iss. 7, pp. 1931-1941
Open Access | Times Cited: 24
Mechanism of action and neurotoxic effects of chronic exposure to bisphenol F in adult zebrafish
Seong Soon Kim, Jiwon L. Kim, Kyu-Seok Hwang, et al.
The Science of The Total Environment (2022) Vol. 851, pp. 158258-158258
Closed Access | Times Cited: 16
The ‘Yin’ and the ‘Yang’ of the kynurenine pathway: excitotoxicity and neuroprotection imbalance in stress-induced disorders
Pascal Barone
Behavioural Pharmacology (2019) Vol. 30, Iss. 2 and 3, pp. 163-186
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top